Friedreich's Ataxia Drug Market – Disease-Modifying...

added blog Health

2026-08-11 06:49:49 -

Friedreich's Ataxia Drug Market – Disease-Modifying Therapies Addressing Mitochondrial Dysfunction

Market Overview The Friedreich's ataxia drug market is advancing as disease-modifying therapies targeting the underlying mitochondrial dysfunction and iron-sulfur cluster deficiency move beyond symptomatic management toward interventions that slow or halt neurodegeneration in this progressive inherited disorder. Caused by frataxin gene triplet repeat expansion, Friedreich's ataxia leads to gait...

0 Comments 0 Shares 264 Views 0 Reviews